GoodRx Holdings, Inc. (GDRX): auditor change — GoodRx replaces PwC with KPMG as independent auditor for FY2026

GoodRx Holdings, Inc.

Audit committee appointed KPMG as independent auditor for FY2026, replacing PwC.
PwC's audit reports for FY2024 and FY2025 were unqualified; no disagreements or reportable events.
No prior consultations with KPMG on accounting principles or audit matters.
Change follows a competitive proposal process; PwC provided an SEC letter confirming agreement.

item 4.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Auditor Changes SEC 8-K Item 4.01/4.02 confidence 0.9

GoodRx Holdings, Inc. engaged KPMG LLP as its auditor.

Action: engagement
Auditor: KPMG LLP

Exact text from the filing

the Audit and Risk Committee of the Board of Directors of GoodRx Holdings, Inc. (the “Company”), following a competitive proposal process, approved the appointment of KPMG LLP (“KPMG”) as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026

View on SEC.gov

Auditor Changes SEC 8-K Item 4.01/4.02 confidence 0.9

GoodRx Holdings, Inc. dismissed PricewaterhouseCoopers LLP as its auditor.

Action: dismissal
Auditor: PricewaterhouseCoopers LLP
Successor: KPMG LLP

Exact text from the filing

approved the dismissal of PricewaterhouseCoopers LLP (“PwC”) as the Company’s independent registered public accounting firm

View on SEC.gov

Browse all auditor changes →

GoodRx Holdings, Inc. filing history →

Source: SEC EDGAR

accession 0001809519-26-000059

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.